Diabetic Patients with Comorbidities had Worse Outcomes When Suffered with COVID-19 and Acarbose might have Protective Effects

作者
Weihua Hu,Shunkui Luo,Zhanjin Lu,Chang Li,Qijian Chen,Yameng Fan,Zaishu Chen,Longlong Wu,Jianfang Ye,Shiyan Chen,Junlu Tong,Lingling Wang,Jin Mei,Hongyun Lu
出处
期刊:Research Square
标识
DOI:10.21203/rs.3.rs-57456/v1
摘要

Abstract Background : Previous studies showed that diabetes was a common comorbidity of COVID-19, but the effects of diabetes or anti-diabetic drugs on the mortality of COVID-19 have not been well described. To investigate the outcome of different status (with or without comorbidity) and anti-diabetic medication before admission of diabetic patients after SARS-CoV-2 infected, we collected clinical data of COVID-19 patients from Hubei Province and compared between diabetes and non-diabetes. Methods : In this multicenter and retrospective study, we enrolled 1,422 cases of consecutive hospitalized patients from January 21, 2020 to March 25, 2020 at six hospitals in Hubei Province, China. The primary endpoint was in-hospital mortality. Results : Diabetes patients were 10-years older than non-diabetes ( p <0.001), had higher prevalence of comorbidities such as hypertension ( p <0.001), coronary heart disease ( p <0.001), cerebrovascular disease (CVD) ( p <0.001), chronic kidney disease (CKD) ( p =0.007). The incidence of mortality ( p =0.003) were more prevalent among the diabetes group. Further analysis revealed that diabetes patients who took alpha-glucosidase inhibitor (AGI) had lower mortality rate( p <0.01). Multivariable Cox regression showed that male sex, hypertension, CKD, CVD, age were risk factors for the mortality of COVID-19. Survival curve revealed that, compared with diabetes only group, the mortality was increased in diabetes with comorbidities ( p =0.009), but had no significant difference in the non-comorbidity group, p =0.59). Conclusions: Patients with diabetes had worse outcome when suffered with COVID-19, however, it was not associated with diabetes itself but the comorbidities. Furthermore, the administration of AGI could reduce the risk of death in patients with diabetes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
宋宋不迷糊完成签到 ,获得积分10
1秒前
1秒前
研友_VZG7GZ的应助被qqq采纳,获得10
2秒前
爆米花的应助被Peter采纳,获得10
3秒前
华北克拉通完成签到,获得积分10
4秒前
糕冷梨发布了新的文献求助10
5秒前
爱你的心完成签到 ,获得积分10
5秒前
传奇3的应助被蟹老板的crab2采纳,获得10
5秒前
开心发布了新的文献求助10
5秒前
Lucas的应助被kai采纳,获得10
6秒前
钟文完成签到,获得积分10
6秒前
南栀发布了新的文献求助10
6秒前
DARLING002完成签到,获得积分10
8秒前
勤恳的香之完成签到,获得积分20
8秒前
3189完成签到 ,获得积分10
10秒前
叽里咕噜不爱吃鱼完成签到,获得积分10
11秒前
MOUMOU发布了新的文献求助10
11秒前
11秒前
Pittes发布了新的文献求助10
11秒前
善良的小怪兽完成签到,获得积分10
12秒前
zheng发布了新的文献求助10
14秒前
Guochunbao完成签到,获得积分10
15秒前
16秒前
Nebula完成签到,获得积分10
17秒前
ZHI完成签到,获得积分10
18秒前
淡然如风发布了新的文献求助10
18秒前
自由文博的应助被勤恳的香之采纳,获得10
19秒前
阔达的千萍完成签到,获得积分10
20秒前
Hello的应助被Jeremy采纳,获得10
20秒前
21秒前
西麓麓发布了新的文献求助10
25秒前
CAOHOU的应助被JPH1990采纳,获得10
26秒前
俭朴映阳完成签到 ,获得积分10
26秒前
爆米花的应助被WLLLR采纳,获得10
29秒前
29秒前
唠叨的富完成签到,获得积分10
30秒前
30秒前
小铃铛完成签到,获得积分10
30秒前
科目三的应助被星辰采纳,获得10
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188339
求助须知:如何正确求助?哪些是违规求助? 9576127
关于积分的说明 21845709
捐赠科研通 7786389
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559588
邀请新用户注册赠送积分活动 2482196